A Simplified Regimen to Prevent Nausea and Vomiting Using Netupitant/Palonosetron in Germ Cell Cancer Patients Receiving Chemotherapy

NCT07662200 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Germ Cell Cancer

Interventions

DRUG: Netupitant/Palonosetron Hydrochloride
DRUG: Ondansetron (Control)
DRUG: Aprepitant
DRUG: Dexamethasone
DRUG: Olanzapine

Sponsor

Ottawa Hospital Research Institute